Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Free Cash Flow: 2021-2025

Historic Free Cash Flow for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to -$14.7 million.

  • ProQR Therapeutics N.V's Free Cash Flow fell 112.98% to -$14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.2 million, marking a year-over-year decrease of 50.70%. This contributed to the annual value of -$43.3 million for FY2024, which is 298.23% down from last year.
  • According to the latest figures from Q3 2025, ProQR Therapeutics N.V's Free Cash Flow is -$14.7 million, which was down 8.94% from -$13.5 million recorded in Q2 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Free Cash Flow peaked at $48.7 million during Q2 2023, and registered a low of -$21.6 million during Q1 2022.
  • Over the past 3 years, ProQR Therapeutics N.V's median Free Cash Flow value was -$9.4 million (recorded in 2023), while the average stood at -$5.3 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 466.29% in 2022, then surged by 407.47% in 2023.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Free Cash Flow stood at $5.0 million in 2021, then tumbled by 466.29% to -$18.2 million in 2022, then surged by 68.53% to -$5.7 million in 2023, then crashed by 87.08% to -$10.7 million in 2024, then tumbled by 112.98% to -$14.7 million in 2025.
  • Its last three reported values are -$14.7 million in Q3 2025, -$13.5 million for Q2 2025, and -$17.2 million during Q1 2025.